Biotech & Manufacturing 

A recognized center for medical devices, imaging, and advanced biohealth manufacturing

The Milwaukee region has a strong and growing presence across life sciences, biohealth, nutraceuticals, and advanced manufacturing, with particular strengths in medical devices, diagnostics, imaging, and specialized production. The ecosystem includes medical device and component manufacturers, health technology firms, and producers that support care delivery across hospitals and health systems around the world. This position is supported by a skilled technical workforce, respected research institutions, and a stable, business‑friendly operating environment that continues to attract investment and support company growth. 

That momentum is increasingly visible. In 2024, Lilly announced a $3.3 billion expansion of its injectable drug manufacturing operations in the region, one of its largest investments outside Indiana, bringing approximately 750 skilled positions. In 2025, GE HealthCare committed an additional $100 million to expand its research, development, and manufacturing footprint in Wisconsin, where the company already employs more than 6,000 people, beginning with a new technology experience center. They join Pfizer, Thermo Fisher Scientific, Microbial Discovery Group, and a deep regional base of contract manufacturers, biologics producers, and medical device firms serving global markets.

Working together to commercialize innovation

AMPDNA is a coalition of academic research facilities formed to help regional healthcare innovators develop drugs, devices, health technology software, and new clinical delivery approaches that address unmet medical needs. The Medical College of Wisconsin, University of Wisconsin-Milwaukee, Concordia University, Marquette University, the Blood Research Institute/Versiti, and the Milwaukee School of Engineering all work together to mobilize research from lab to market.